BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Evers S, Calcagnoli F, van Dijk G, Scheurink A. Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats. Pharmacology Biochemistry and Behavior 2010;97:163-9. [DOI: 10.1016/j.pbb.2010.05.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Razavi BM, Abazari AR, Rameshrad M, Hosseinzadeh H. Carnosic acid prevented olanzapine-induced metabolic disorders through AMPK activation. Mol Biol Rep 2020;47:7583-92. [PMID: 32929650 DOI: 10.1007/s11033-020-05825-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Boyda HN, Procyshyn RM, Tse L, Wong D, Pang CC, Honer WG, Barr AM. Intermittent treatment with olanzapine causes sensitization of the metabolic side-effects in rats. Neuropharmacology 2012;62:1391-400. [PMID: 21376062 DOI: 10.1016/j.neuropharm.2011.02.019] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
3 Lian J, De Santis M, He M, Deng C. Risperidone-induced weight gain and reduced locomotor activity in juvenile female rats: The role of histaminergic and NPY pathways. Pharmacological Research 2015;95-96:20-6. [DOI: 10.1016/j.phrs.2015.03.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
4 Szota AM, Araszkiewicz AS. The risk factors, frequency and diagnosis of atypical antipsychotic drug-induced hypothermia: practical advice for doctors. Int Clin Psychopharmacol 2019;34:1-8. [PMID: 30398998 DOI: 10.1097/YIC.0000000000000244] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
5 Tungalag T, Yoo Y, Tae H, Yang DK. Olanzapine-Induced Therapeutic Hypothermia Attenuates Renal Injury in Rats after Asphyxial Cardiac Arrest and Resuscitation. Antioxidants 2022;11:443. [DOI: 10.3390/antiox11030443] [Reference Citation Analysis]
6 Steiner J, Bernstein HG, Schiltz K, Müller UJ, Westphal S, Drexhage HA, Bogerts B. Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma. Prog Neuropsychopharmacol Biol Psychiatry 2014;48:287-94. [PMID: 23085507 DOI: 10.1016/j.pnpbp.2012.09.016] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 5.0] [Reference Citation Analysis]
7 Girault EM, Guigas B, Alkemade A, Foppen E, Ackermans MT, la Fleur SE, Fliers E, Kalsbeek A. Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects. Naunyn-Schmiedeberg's Arch Pharmacol 2014;387:185-95. [DOI: 10.1007/s00210-013-0933-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
8 Singh R, Bansal Y, Sodhi RK, Saroj P, Medhi B, Kuhad A. Modeling of antipsychotic-induced metabolic alterations in mice: An experimental approach precluding psychosis as a predisposing factor. Toxicology and Applied Pharmacology 2019;378:114643. [DOI: 10.1016/j.taap.2019.114643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
9 Zhang Q, Deng C, Huang X. The role of ghrelin signalling in second-generation antipsychotic-induced weight gain. Psychoneuroendocrinology 2013;38:2423-38. [DOI: 10.1016/j.psyneuen.2013.07.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
10 Evers SS, Boersma GJ, Tamashiro KL, Scheurink AJ, van Dijk G. Roman high and low avoidance rats differ in their response to chronic olanzapine treatment at the level of body weight regulation, glucose homeostasis, and cortico-mesolimbic gene expression. J Psychopharmacol 2017;31:1437-52. [PMID: 28892416 DOI: 10.1177/0269881117724749] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
11 Razavi BM, Lookian F, Hosseinzadeh H. Protective effects of green tea on olanzapine-induced-metabolic syndrome in rats. Biomedicine & Pharmacotherapy 2017;92:726-31. [DOI: 10.1016/j.biopha.2017.05.113] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
12 Benarroch L, Kowalchuk C, Wilson V, Teo C, Guenette M, Chintoh A, Nesarajah Y, Taylor V, Selby P, Fletcher P, Remington GJ, Hahn MK. Atypical antipsychotics and effects on feeding: from mice to men. Psychopharmacology (Berl) 2016;233:2629-53. [PMID: 27251130 DOI: 10.1007/s00213-016-4324-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 3.5] [Reference Citation Analysis]
13 Dias FRC, de Matos LW, dos Santos Sampaio MDF, Carey RJ, Carrera MP. Residual dopamine receptor desensitization following either high- or low-dose sub-chronic prior exposure to the atypical anti-psychotic drug olanzapine. Psychopharmacology 2013;225:141-50. [DOI: 10.1007/s00213-012-2802-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
14 van der Zwaal EM, Janhunen SK, la Fleur SE, Adan RA. Modelling olanzapine-induced weight gain in rats. Int J Neuropsychopharmacol 2014;17:169-86. [PMID: 24103788 DOI: 10.1017/S146114571300093X] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
15 Smith RC, Rachakonda S, Dwivedi S, Davis JM. Olanzapine and risperidone effects on appetite and ghrelin in chronic schizophrenic patients. Psychiatry Res 2012;199:159-63. [PMID: 22475524 DOI: 10.1016/j.psychres.2012.03.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
16 Evers SS, van Vliet A, van Vugt B, Scheurink AJ, van Dijk G. A low TSH profile predicts olanzapine-induced weight gain and relief by adjunctive topiramate in healthy male volunteers. Psychoneuroendocrinology 2016;66:101-10. [DOI: 10.1016/j.psyneuen.2015.12.024] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang Q, Lian J, He M, Deng C, Wang H, Huang XF. Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats. Prog Neuropsychopharmacol Biol Psychiatry 2014;51:172-80. [PMID: 24548587 DOI: 10.1016/j.pnpbp.2014.02.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
18 Yang F, Chen L, Fang X, Zheng K, Zhu C, Xu C, Zhang C, Tang W. Influence of olanzapine on serum prolactin levels and BMI in female patients with schizophrenia. Neuropsychiatr Dis Treat 2018;14:3373-9. [PMID: 30587989 DOI: 10.2147/NDT.S180303] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 van der Zwaal EM, Merkestein M, Lam YK, Brans MAD, Luijendijk MCM, Bok LIH, Verheij ER, la Fleur SE, Adan RAH. The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature. Int J Obes 2012;36:254-61. [DOI: 10.1038/ijo.2011.97] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]